Mr. David Rezvani, President and CEO of Foxspire, began his career as a software developer in 1999 in the biosciences field. For three years he developed several National Library of Medicine (NLM) and National Institute of Allergy and Infectious Diseases (NIAID) Website projects. He managed a complex web application for NIAID’s Division of Acquired Immunodeficiency Syndrome (DAIDS) to display Anti-HIV chemical compounds, chemical structures, and biological data for national and international research communities. His success lead to the expansion of this project to include compounds active against other viruses in collaboration with NIAID’s Division of Microbiology and Infectious Diseases (DMID).

In 2004, Mr. Rezvani began working for the United States Army Medical Research Institute of Infectious Disease (USAMRIID) at Fort Detrick in Frederick, MD. He was assigned to the Biosafety Division and began researching the issues surrounding inventory control in relation to the use and storage of biological select agents and toxins (BSAT). It was requested that he develop a unique inventory database tracking system that would meet the requirements of the Select Agent Program (SAP) CDC Regulations.

In 2005, Mr. Rezvani successfully deployed the institute’s SAP inventory database system called the Agent Inventory Management System (AIMS). Over the past several years, he has become highly experienced in guiding the organization’s IT needs in the pursuit of compliance to laws and regulations and assisted with numerous inspections related to inventory discrepancies.

Consequently, Mr. Rezvani pursued a Technology Transfer of the AIMS to bring it to the commercial market to assist other laboratories facing similar challenges of inventory control and tracking.

From his experience marketing the commercial database, he saw a need for small labs to utilize a more cost effective inventory solution. This realization led to the creation of VialWorks.